GO:1904784 NLRP1 inflammasome complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904784 describes the aggregation, arrangement and bonding of components to form the NLRP1 inflammasome complex, a cytosolic innate immune signaling platform [2,4].
• NLRP1 is a sensor of pathogen- and damage-associated patterns, including viral 3CL proteases and KSHV ORF45, triggering inflammasome assembly [7,8].
• Assembly requires NLRP1 oligomerization, ASC recruitment, and caspase-1 activation, leading to IL-1beta/IL-18 maturation and pyroptosis [2,4,5].
• Human NLRP1 and CARD8 share structural features but assemble distinct inflammasome complexes with different stoichiometries.
• Dysregulated NLRP1 inflammasome assembly is implicated in skin diseases, neurodegenerative conditions, and cancer [1,6].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect NLRP1 assembly mechanisms and therapeutic targets [2,6].
Description
NLRP1 inflammasome complex assembly (GO:1904784) is the biological process by which a set of cytosolic proteins aggregates and bonds to form a functional NLRP1 inflammasome, a multiprotein platform that activates inflammatory caspases [2,4]. This process is a cornerstone of innate immunity, enabling detection of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). The NLRP1 inflammasome is unique among inflammasomes because it is directly activated by proteolytic cleavage, for example by viral 3CL proteases or KSHV ORF45, rather than by a simple ligand-binding event [7,8]. Understanding GO:1904784 is therefore critical for researchers studying host-pathogen interactions, inflammatory cell death, and autoinflammatory diseases [1,6]. The assembly process involves multiple steps: sensor activation, oligomerization, adaptor recruitment, and effector activation [2,4]. Each step offers potential therapeutic targets and requires precise experimental models to dissect. This article provides a research-grade overview of GO:1904784, integrating authoritative QuickGO data with verified PubMed literature to support CRISPR-based investigations.
NLRP1 inflammasome complex assembly At A Glance
| GO ID | GO:1904784 |
|---|---|
| GO term | NLRP1 inflammasome complex assembly |
| Ontology | biological_process |
| Synonym | NALP1 inflammasome complex assembly; NALP1 inflammasome complex formation; NLRP1 inflammasome complex formation |
| Major function | Assembly of a multiprotein inflammasome platform that activates caspase-1 and inflammatory cytokines [2,4] |
| Key sensor | NLRP1 (NACHT, LRR and PYD domains-containing protein 1) [4,6] |
| Adaptor protein | ASC (apoptosis-associated speck-like protein containing a CARD) [2,4] |
| Effector enzyme | Caspase-1 [2,5] |
| Downstream outcomes | IL-1beta and IL-18 maturation, pyroptosis [5,6] |
| Disease relevance | Skin inflammation, neurodegenerative diseases, cancer [1,6] |
What Is GO:1904784?
GO:1904784, NLRP1 inflammasome complex assembly, is defined as the aggregation, arrangement and bonding together of a set of components to form a NLRP1 inflammasome complex [2,4]. In simpler terms, it is the step-by-step construction of a molecular machine that detects danger signals and triggers inflammation. This process is a biological process (ontology aspect) and is synonymous with NALP1 inflammasome complex assembly and NLRP1 inflammasome complex formation.
Why Is NLRP1 inflammasome complex assembly Important in Cell Biology?
GO:1904784 is important because NLRP1 inflammasome assembly is a central node in innate immune signaling, and its dysregulation contributes to a wide range of human pathologies, including autoinflammatory skin diseases, neurodegenerative disorders, and cancer [1,6]. Unlike other inflammasomes, NLRP1 is directly activated by proteolytic cleavage, making it a unique sensor of viral proteases and a potential target for antiviral and anti-inflammatory therapies [7,8]. Understanding the molecular steps of assembly is essential for developing specific inhibitors and for interpreting genetic variants associated with disease [2,4].
• NLRP1 inflammasome assembly is a key innate immune mechanism against viral and bacterial pathogens [5,7].
• Dysregulated assembly is linked to skin inflammatory diseases such as psoriasis and vitiligo.
• NLRP1 inflammasome activation contributes to neuroinflammation in Alzheimer's and Parkinson's diseases.
• Assembly is triggered by pathogen-derived proteases, offering a target for antiviral strategies.
• Human NLRP1 and CARD8 assemble distinct complexes, highlighting structural diversity.
• CRISPR knockout of NLRP1 or ASC can abolish assembly and downstream cytokine release [2,6].
• Point mutations in NLRP1 can cause constitutive assembly and autoinflammatory syndromes.
• Assembly is regulated by post-translational modifications and cellular stress.
• Modeling assembly in human cells requires careful choice of cell type due to species differences.
• Bioinformatics and CRISPR library screening can identify novel regulators of GO:1904784 [2,5].
What Happens During NLRP1 inflammasome complex assembly?
Sensor activation and conformational change
In simple terms: NLRP1 changes shape when it detects a danger signal.
NLRP1 is activated by proteolytic cleavage or ligand binding, which relieves autoinhibition and exposes the NACHT domain for oligomerization [2,4]. Viral 3CL proteases and KSHV ORF45 directly cleave human NLRP1, triggering assembly [7,8].
NLRP1 oligomerization and ASC recruitment
In simple terms: Multiple NLRP1 molecules stick together and recruit an adaptor protein.
Activated NLRP1 oligomerizes via its NACHT domain and recruits ASC through PYD-PYD interactions, forming a large signaling platform [2,4]. This step is essential for caspase-1 activation.
Caspase-1 activation and inflammasome speck formation
In simple terms: The assembled platform activates an enzyme that triggers inflammation.
ASC nucleates caspase-1 filaments, leading to caspase-1 autoproteolytic activation and formation of a single large speck per cell [2,5]. Active caspase-1 then cleaves pro-IL-1beta and pro-IL-18.
Downstream signaling and pyroptosis
In simple terms: The active inflammasome causes cytokine release and cell death.
Mature IL-1beta and IL-18 are secreted, and gasdermin D cleavage induces pyroptosis, a lytic form of cell death that amplifies inflammation [5,6].
Regulation and termination
In simple terms: The process is tightly controlled to avoid excessive inflammation.
Assembly is regulated by phosphorylation, ubiquitination, and interaction with other proteins; dysregulation leads to chronic inflammation [1,5].
Key Genes Involved in GO:1904784 NLRP1 inflammasome complex assembly
The following genes and proteins are central to NLRP1 inflammasome complex assembly (GO:1904784) and are frequently studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP1 | Sensor and core scaffold of the inflammasome | Knockout abolishes assembly; point mutations cause autoinflammation [2,4] |
| ASC (PYCARD) | Adaptor linking NLRP1 to caspase-1 | Knockout prevents speck formation and cytokine release [2,5] |
| Caspase-1 (CASP1) | Effector protease that matures IL-1beta/IL-18 | Knockout blocks downstream signaling |
| CARD8 | Related sensor with distinct assembly properties | Comparative studies reveal structural differences |
| IL-1beta (IL1B) | Pro-inflammatory cytokine | Readout of inflammasome activation |
| IL-18 (IL18) | Pro-inflammatory cytokine | Readout of inflammasome activation |
| GSDMD | Pore-forming protein for pyroptosis | Knockout prevents cell death |
| NEK7 | Mediator of NLRP3 activation, not NLRP1 | Control for specificity |
| KSHV ORF45 | Viral activator of human NLRP1 | Used to study pathogen-triggered assembly |
| 3CL protease | Viral protease that cleaves NLRP1 | Coronavirus sensor mechanism |
| NLRP3 | Related inflammasome sensor | Comparative studies |
| AIM2 | Related inflammasome sensor | Comparative studies |
| NLRC4 | Related inflammasome sensor | Comparative studies |
| POP1 | Pyrin-only protein, potential regulator | May modulate assembly |
| POP2 | Pyrin-only protein, potential regulator | May modulate assembly |
| CARD8 | Structural homolog of NLRP1 | Distinct assembly mechanisms |
| TRIM21 | E3 ligase, potential regulator | May affect NLRP1 stability |
| BRCC3 | Deubiquitinase, potential regulator | May affect NLRP1 activation |
How Is NLRP1 inflammasome complex assembly Regulated?
NLRP1 inflammasome complex assembly is regulated at multiple levels. Post-translational modifications such as phosphorylation and ubiquitination control NLRP1 stability and activation. Viral proteases can directly cleave NLRP1 to trigger assembly, while host factors like POP1 and POP2 may inhibit it [4,7]. Additionally, cellular stress and ion flux can modulate assembly, though the exact mechanisms remain under investigation [1,5].
NLRP1 inflammasome complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP1 | Psoriasis, vitiligo, autoinflammation | Keratinocyte knockout and point-mutation models |
| NLRP1 | Alzheimer's disease neuroinflammation | Neuronal overexpression and knockout |
| CASP1 | Inflammatory bowel disease | Intestinal organoid knockout |
| GSDMD | Pyroptosis-related pathologies | Knockout macrophages |
| ASC | Autoinflammatory syndromes | Knockout THP-1 cells |
NLRP1 inflammasome in skin diseases
NLRP1 is highly expressed in keratinocytes, and its dysregulated assembly contributes to inflammatory skin conditions such as psoriasis, vitiligo, and skin cancer. Gain-of-function mutations in NLRP1 cause autoinflammatory syndromes with skin manifestations.
Neurodegenerative diseases
Inflammasome assembly, including NLRP1, is implicated in neuroinflammation associated with Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Targeting NLRP1 assembly may reduce neuronal damage.
Cancer
NLRP1 inflammasome activity can have dual roles in cancer, promoting anti-tumor immunity or driving chronic inflammation that supports tumor growth. Understanding assembly mechanisms may inform cancer immunotherapy.
Viral infections
Human NLRP1 senses coronavirus 3CL proteases and KSHV ORF45, leading to inflammasome assembly and antiviral responses [7,8]. This highlights NLRP1 as a viral sensor and potential therapeutic target.
From NLRP1 inflammasome complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NLRP1 drive inflammasome assembly? | NLRP1 knockout in human keratinocytes or THP-1 cells [2,6] |
| Which residues are required for cleavage? | Point mutations at cleavage sites in NLRP1 [2,8] |
| Can a disease variant cause constitutive assembly? | Knock-in of patient mutations in cell lines |
| Where does assembly occur in the cell? | Tagged knock-in of NLRP1 with fluorescent protein |
| Can overexpression trigger assembly? | Overexpression of NLRP1 and ASC in HEK293T cells |
| What regulators modulate assembly? | CRISPR library screening in macrophages |
How to Study the NLRP1 inflammasome complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Test necessity of NLRP1, ASC, caspase-1 |
| Point mutation knock-in | Effect of specific residues | Cleavage site mutants |
| Overexpression | Gain of function | Trigger assembly in HEK293T |
| Immunoblotting | Protein cleavage and activation | Caspase-1 and IL-1beta processing |
| ELISA | Cytokine secretion | IL-1beta and IL-18 release |
| Fluorescence microscopy | Speck formation | ASC polymerization |
| RNA-seq | Transcriptional changes | Inflammatory gene expression |
| Proteomics | Protein interactions | Inflammasome complex composition |
CRISPR knockout and knock-in models
CRISPR-Cas9 knockout of NLRP1, ASC, or caspase-1 is used to test necessity for assembly and downstream signaling [2,6]. Knock-in of point mutations or tags allows precise dissection of cleavage and localization [2,8].
Biochemical assays for assembly
Immunoprecipitation, native PAGE, and crosslinking can detect NLRP1 oligomerization and ASC speck formation [2,4]. Caspase-1 activity and IL-1beta ELISA are standard readouts.
Imaging of inflammasome specks
Fluorescence microscopy with ASC-fluorescent protein fusions visualizes speck formation in live cells [2,5]. This method confirms assembly in situ.
Transcriptomic and proteomic profiling
RNA-seq and mass spectrometry identify gene expression changes and protein interactions during assembly [1,5]. These approaches can reveal novel regulators.
How CRISPR Can Be Used to Study GO:1904784 NLRP1 inflammasome complex assembly
Knockout
CRISPR knockout of NLRP1, ASC, or caspase-1 abolishes inflammasome assembly and downstream cytokine release, providing definitive evidence of their essential roles [2,6].
Point Mutation
Point mutations at cleavage sites or in the NACHT domain can prevent or constitutively activate assembly, helping map functional domains [2,8].
Knock-in
Knock-in of fluorescent tags or patient-derived mutations allows real-time visualization and disease modeling of NLRP1 assembly [2,4].
Overexpression
Overexpression of NLRP1 and ASC in HEK293T cells is a common method to reconstitute assembly and test regulators.
How EDITGENE Supports NLRP1 inflammasome complex assembly Research
Researchers studying NLRP1 inflammasome complex assembly-related genes often need to determine whether a candidate gene is causally involved in assembly, cytokine release, or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for NLRP1 inflammasome complex assembly research.
Frequently Asked Questions About NLRP1 inflammasome complex assembly
What is NLRP1 inflammasome complex assembly?
It is the biological process (GO:1904784) by which NLRP1, ASC, and caspase-1 aggregate to form a functional inflammasome platform that triggers inflammation [2,4].
What genes are involved in NLRP1 inflammasome complex assembly?
Key genes include NLRP1, ASC (PYCARD), caspase-1 (CASP1), IL1B, IL18, and GSDMD [2,5].
How is NLRP1 inflammasome assembly activated?
It is activated by proteolytic cleavage of NLRP1 by pathogen proteases such as coronavirus 3CL protease or KSHV ORF45, or by danger signals [7,8].
What diseases are linked to NLRP1 inflammasome assembly?
Dysregulated assembly is linked to skin inflammatory diseases, neurodegenerative diseases, and cancer [1,6].
What is the difference between NLRP1 and NLRP3 inflammasomes?
NLRP1 is activated by direct cleavage, while NLRP3 requires NEK7 and potassium efflux; they assemble distinct complexes [2,3].
How can I study NLRP1 inflammasome assembly in the lab?
Common methods include CRISPR knockout, immunoblotting for caspase-1, ELISA for IL-1beta, and fluorescence microscopy for ASC specks [2,5].
What cell models are best for NLRP1 inflammasome research?
Human keratinocytes, THP-1 macrophages, and HEK293T reconstitution systems are widely used [2,6].
Can CRISPR be used to model NLRP1 autoinflammatory mutations?
Yes, knock-in of patient-derived point mutations in NLRP1 can recapitulate constitutive assembly and inflammation.
What are the downstream effects of NLRP1 inflammasome assembly?
Activation leads to caspase-1-dependent maturation of IL-1beta and IL-18, and pyroptosis via gasdermin D.
How does EDITGENE support NLRP1 inflammasome research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics services tailored to inflammasome studies [2,5].
Conclusion
NLRP1 inflammasome complex assembly (GO:1904784) is a fundamental innate immune process with broad implications for infectious, inflammatory, and neurodegenerative diseases [1,5]. Understanding its molecular steps and regulation requires precise experimental models, where CRISPR-based approaches are indispensable [2,6]. EDITGENE provides comprehensive services to accelerate research on this critical pathway.
References
- 1. Singh J et al.. 2023. Inflammasome assembly in neurodegenerative diseases.. Trends Neurosci 46(10):814-831 PMID: 37633753
- 2. Gong Q et al.. 2021. Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8.. Nat Commun 12(1):188 PMID: 33420028
- 3. He Y et al.. 2016. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.. Nature 530(7590):354-7 PMID: 26814970
- 4. Chavarría-Smith J et al.. 2015. The NLRP1 inflammasomes.. Immunol Rev 265(1):22-34 PMID: 25879281
- 5. Dubey SR et al.. 2025. Molecular mechanisms and regulation of inflammasome activation and signaling: sensing of pathogens and damage molecular patterns.. Cell Mol Immunol 22(11):1313-1344 PMID: 41062723
- 6. Fenini G et al.. 2020. The NLRP1 Inflammasome in Human Skin and Beyond.. Int J Mol Sci 21(13) PMID: 32640751
- 7. Yang X et al.. 2022. KSHV-encoded ORF45 activates human NLRP1 inflammasome.. Nat Immunol 23(6):916-926 PMID: 35618833
- 8. Planès R et al.. 2022. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells.. Mol Cell 82(13):2385-2400.e9 PMID: 35594856
